Gilead Sciences Inc
Stock Chart, Company Information, and Scan Results
$123.76(as of Jun 18, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Gilead Sciences Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$123.76
Ticker SymbolGILD
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - General
Employees17,000
CountyUSA
Market Cap$153,656.7M
EBIDTA14,738.0M
10-Day Moving Average125.15
P/E Ratio16.84
20-Day Moving Average128.13
Forward P/E Ratio15.22
50-Day Moving Average130.99
Earnings per Share7.35
200-Day Moving Average127.79
Profit Margin29.04%
RSI40.43
Shares Outstanding1,241.6M
ATR3.59
52-Week High155.38
Volume14,348,300
52-Week Low101.81
Book Value23,431.0M
P/B Ratio6.62
Upper Keltner136.22
P/S Ratio5.22
Lower Keltner120.05
Debt-to-Equity Ratio136.22
Next Earnings Date08/05/2026
Cash Surplus-1,848.0M
Next Ex-Dividend DateUnknown
Add good karma to your portfolio with GILD. This research-based biopharmaceutical company is making the world a better place by developing and commercializing medicines for life-threatening diseases like HIV/AIDS, liver diseases, and cancer. Gilead’s HIV treatments, including Truvada and Atripla, have helped transform the chronic disease into a manageable condition. Their treatments are responsible for saving millions of lives.
Gilead Sciences Inc In Our Stock Scanner
As of Jun 22, 2026
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.